The largest database of trusted experimental protocols

β nad

Manufactured by bioMérieux
Sourced in France

β-NAD is a coenzyme product offered by bioMérieux. It serves as an essential cofactor for various enzymatic reactions in biological systems.

Automatically generated - may contain errors

3 protocols using β nad

1

Antimicrobial Potency of OEO-PbH Compound

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial properties of OEO-PbH was evaluated by dilution method according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST), Clinical Laboratory and Standard Institute (CLSI), and other previous studies [42 (link),43 ,44 (link),45 (link),46 (link)].
Seven microorganisms were tested for their susceptibility to OEO-PbH. From each microbial strain, standardized suspensions were prepared to a concentration of 0.5 MacFarland, approximatively 108 CFU/mL (CFU—colony forming unit). Then, broth was added (Mueller–Hinton or Mueller–Hinton supplemented with defibrinated horse blood and β-NAD, bioMérieux, Craponne, France) and serial dilutions were obtained from OEO-PbH, obtaining a final microbial density of approximately 105 CFU/mL. After incubating at 35–37 °C for 24 h, MIC was read. MIC is defined as the lowest concentration of the test compounds without visible growth. To determine MBC or MFC, a volume of 1 µL from the test tubes with no visible growth was inoculated on solid culture media (Columbia agar + 5% sheep blood or Sabouraud Dextrose Agar, bioMérieux, France). The lowest concentration which killed 99.9% of the microorganisms was established after being incubated at 35–37 °C for 24 h. In the same mode OEO was also tested as positive control and the excipient as negative control.
+ Open protocol
+ Expand
2

Antibiotic Susceptibility of Listeria monocytogenes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The disk-diffusion method was applied to determine antibiotic susceptibility of L. monocytogenes strains tested. For this purpose, 24 h bacterial cultures diluted in 0.9% saline solution (Avantor, Gliwice, Poand) were plated on MHF medium (Mueller Hinton Agar with 5.0% horse blood and 20 mg/L β-NAD; bioMérieux, Marcy-l’Étoile, France). Next, following antibiotic discs were added: penicillin (1 IU), ampicillin (2 μg), meropenem (10 μg), erythromycin (15 μg), and cotrimoxazole (1.25–23.75 μg). The antibiotics for the studies were selected in accordance with the European Committee on Antimicrobial Susceptibility Testing (EUCAST) v. 8.0 [26 ] recommendations. The antibiotics used in the study are the only ones that can be used in Europe to treat listeriosis and for which the interpretation of the results is possible. After 20 h of incubation at 35 °C, growth inhibition zones around the antibiotic discs were measured and analyzed in accordance with the EUCAST v. 8.0 [26 ].
+ Open protocol
+ Expand
3

Antimicrobial Susceptibility of Campylobacter jejuni

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial susceptibility was performed by the agar diffusion method according to the criteria proposed by the CA-SFM and harmonized according to the criteria proposed by EUCAST (EUCAST, 2018): MH-F medium (Mueller-Hinton + 5% defibrinated horse blood and 20 mg/L β-NAD) (bioMérieux, Marcy l'Etoile, France) was used with an inoculum corresponding to 0.5
McFarland. Six antibiotics belonging to five families were tested: Ampicillin, Amoxicillin-clavulanic acid (beta-lactams), ciprofloxacin (quinolones), erythromycin (macrolides), tetracycline (cyclines) and gentamicin (aminosides). The plates were incubated in microaerobic atmosphere conditions at 35 ± 2°C, 24 h in microaerobic jar conditions (generation of atmosphere using a Anoxomat (Smart)). The reading at 24 h (or 48 h) was performed using the SIRScan system (I2A, Montpellier, France) then visual verification of the diameters read on the camera. A biologist always checks the values read. At the validation, any discrepancy with the result reported by the correspondent was verified and if necessary indicated on the final report. Campylobacter jejuni ATCC 33560 was used as quality control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!